Similar articles for PMID: 28449207

Year	Number of Results
2011	2
2012	1
2013	6
2014	4
2015	6
2016	16
2017	25
2018	20
2019	14
2020	14
2021	23
2022	25
2023	3
2024	0

1

Targeting anti-apoptotic BCL2 family proteins in haematological malignancies - from pathogenesis to treatment.

Vogler M, Walter HS, Dyer MJS. Vogler M, et al. Br J Haematol. 2017 Aug;178(3):364-379. doi: 10.1111/bjh.14684. Epub 2017 Apr 27. Br J Haematol. 2017. PMID: 28449207 Free article. Review.

2

Targeting BCL2 in Chronic Lymphocytic Leukemia and Other Hematologic Malignancies.

Yalniz FF, Wierda WG. Yalniz FF, et al. Drugs. 2019 Aug;79(12):1287-1304. doi: 10.1007/s40265-019-01163-4. Drugs. 2019. PMID: 31313099 Review.

3

BH3 Mimetics in Hematologic Malignancies.

Klener P, Sovilj D, Renesova N, Andera L. Klener P, et al. Int J Mol Sci. 2021 Sep 21;22(18):10157. doi: 10.3390/ijms221810157. Int J Mol Sci. 2021. PMID: 34576319 Free PMC article. Review.

4

Therapeutic development and current uses of BCL-2 inhibition.

Roberts AW. Roberts AW. Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):1-9. doi: 10.1182/hematology.2020000154. Hematology Am Soc Hematol Educ Program. 2020. PMID: 33275682 Free PMC article. Review.

5

Targeting BCL2 With BH3 Mimetics: Basic Science and Clinical Application of Venetoclax in Chronic Lymphocytic Leukemia and Related B Cell Malignancies.

Roberts AW, Huang D. Roberts AW, et al. Clin Pharmacol Ther. 2017 Jan;101(1):89-98. doi: 10.1002/cpt.553. Epub 2016 Nov 26. Clin Pharmacol Ther. 2017. PMID: 27806433 Free PMC article. Review.

6

Therapeutics targeting Bcl-2 in hematological malignancies.

Ruefli-Brasse A, Reed JC. Ruefli-Brasse A, et al. Biochem J. 2017 Oct 23;474(21):3643-3657. doi: 10.1042/BCJ20170080. Biochem J. 2017. PMID: 29061914 Review.

7

BCL2 and MCL1 inhibitors for hematologic malignancies.

Roberts AW, Wei AH, Huang DCS. Roberts AW, et al. Blood. 2021 Sep 30;138(13):1120-1136. doi: 10.1182/blood.2020006785. Blood. 2021. PMID: 34320168 Free article. Review.

8

Targeting BCL2 for the treatment of lymphoid malignancies.

Anderson MA, Huang D, Roberts A. Anderson MA, et al. Semin Hematol. 2014 Jul;51(3):219-27. doi: 10.1053/j.seminhematol.2014.05.008. Epub 2014 May 15. Semin Hematol. 2014. PMID: 25048785 Free article. Review.

9

Apoptosis targeted therapies in acute myeloid leukemia: an update.

Ball S, Borthakur G. Ball S, et al. Expert Rev Hematol. 2020 Dec;13(12):1373-1386. doi: 10.1080/17474086.2020.1852923. Epub 2020 Dec 6. Expert Rev Hematol. 2020. PMID: 33205684 Review.

10

Enhancing venetoclax activity in hematological malignancies.

Satta T, Grant S. Satta T, et al. Expert Opin Investig Drugs. 2020 Jul;29(7):697-708. doi: 10.1080/13543784.2020.1789588. Epub 2020 Jul 16. Expert Opin Investig Drugs. 2020. PMID: 32600066 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

135 results

Results by year